Literature DB >> 16905690

Ablating Barrett's metaplastic epithelium: are the techniques ready for clinical use?

J J G H M Bergman1, P Fockens.   

Abstract

Mesh：

Year:  2006        PMID： 16905690      PMCID： PMC1860019          DOI： 10.1136/gut.2006.092106

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  19 in total

1.  Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation.

Authors:  A Shand; H Dallal; K Palmer; S Ghosh; M MacIntyre
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 2.  Reversal of Barrett's esophagus with electrocoagulation and laser.

Authors:  R E Sampliner
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

3.  Let the patient beware: the evolving truth about laparoscopic antireflux surgery.

Authors:  Joel E Richter
Journal:  Am J Med       Date:  2003-01       Impact factor: 4.965

4.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.

Authors:  M Skacel; R E Petras; T L Gramlich; J E Sigel; J E Richter; J R Goldblum
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

5.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Authors:  B J Reid; L J Prevo; P C Galipeau; C A Sanchez; G Longton; D S Levine; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

6.  Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.

Authors:  J L Van Laethem; M O Peny; I Salmon; M Cremer; J Devière
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

7.  A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.

Authors:  P Sharma; S Wani; A P Weston; A Bansal; M Hall; S Mathur; A Prasad; R E Sampliner
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

8.  Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus.

Authors:  Lybus C Hillman; Louise Chiragakis; Bruce Shadbolt; Graham L Kaye; Anthony C Clarke
Journal:  Med J Aust       Date:  2004-04-19       Impact factor: 7.738

9.  Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery.

Authors:  Roger Ackroyd; William Tam; Mark Schoeman; Peter G Devitt; David I Watson
Journal:  Gastrointest Endosc       Date:  2004-01       Impact factor: 9.427

10.  Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery.

Authors:  Brant K Oelschlager; Marc Barreca; Lilly Chang; Dmitry Oleynikov; Carlos A Pellegrini
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969
View more
  1 in total

1.  Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned.

Authors:  Vic Velanovich
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.